original ) (raw )Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
Luisa Pierro
Scientific Reports
View PDFchevron_right
Visual Function Response to Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole: The OASIS Study
Benedicte Lescrauwaet
Investigative ophthalmology & visual science, 2017
View PDFchevron_right
Initial experience with ocriplasmin in the treatment of vitreomacular traction
David Isaac
Arquivos Brasileiros de Oftalmologia, 2016
View PDFchevron_right
A retrospective study of a single practice use of ocriplasmin in the treatment of vitreomacular traction
Igor Kozak
Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society, 2014
View PDFchevron_right
Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
P. Carpineto
Journal of ophthalmology, 2016
View PDFchevron_right
Association Between Anatomical Resolution and Functional Outcomes in the Mivi-Trust Studies Using Ocriplasmin to Treat Symptomatic Vitreomacular Adhesion/Vitreomacular Traction, Including When Associated with Macular Hole
Anselm Kampik
Retina, 2015
View PDFchevron_right
Impact of Vitreoretinal Interface Architecture on Successful Vitreomacular Traction Resolution in Eyes Scheduled for Intravitreal Ocriplasmin Therapy
sara kazerounian
Retina, 2017
View PDFchevron_right
Visual Function Response To Ocriplasmin For The Treatment Of Vitreomacular Traction And Macular Hole
Benedicte Lescrauwaet
Value in Health, 2014
View PDFchevron_right
Ocriplasmin in the treatment of vitreomacular traction - for
Giuseppe Mannino
Acta Ophthalmologica, 2017
View PDFchevron_right
Characterization of Vitreoretinal Interface Disorders Using OCT in the Interventional Phase 3 Trials of Ocriplasmin
Sandra Stinnett
Investigative Ophthalmology & Visual Science, 2012
View PDFchevron_right
Treatment Outcomes and Spectral-Domain Optical Coherence Tomography Findings of Eyes With Symptomatic Vitreomacular Adhesion Treated With Intravitreal Ocriplasmin
Auvni Patel
American Journal of Ophthalmology, 2015
View PDFchevron_right
Effect of ocriplasmin on the management of macular holes: assessment of the clinical relevance of ocriplasmin
Iris Moroz
JAMA ophthalmology, 2014
View PDFchevron_right
Ocriplasmin versus vitrectomy for the treatment of macular holes
David Chow
Canadian Journal of Ophthalmology, 2018
View PDFchevron_right
Initial Outcomes Following Intravitreal Ocriplasmin for Treatment of Symptomatic Vitreomacular Adhesion
Jaclyn Kovach , William Smiddy
Ophthalmic Surgery, Lasers and Imaging Retina, 2013
View PDFchevron_right
Redesigning services for the management of vitreomacular traction and macular hole
W. Amoaku
Eye, 2014
View PDFchevron_right
Six months follow up of a single intravitreal injection of ocriplasmin for symptomatic vitreomacular adhesion
Elena Pacella
Senses and Sciences, 2016
View PDFchevron_right
Incomplete vitreomacular traction release using intravitreal ocriplasmin
Stephen Russell , James Folk
Case reports in ophthalmology
View PDFchevron_right
Acute loss of vision after an intravitreal injection ocriplasmin: a functional evolutionary study for 1-year follow-up
Francisco Gomez-ulla
Documenta Ophthalmologica, 2015
View PDFchevron_right
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
Benedicte Lescrauwaet
Journal of market access & health policy, 2016
View PDFchevron_right
Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes
Anselm Kampik
New England Journal of Medicine, 2012
View PDFchevron_right
Vitreomacular Changes after Intravitreal Gas Injection for Idiopathic Impending or Early Macular Hole: An Optical Coherence Tomography Study
Ta-Ching Chen
Ophthalmologica, 2017
View PDFchevron_right
Spontaneous Resolution of Vitreomacular Traction Demonstrated by Spectral-Domain Optical Coherence Tomography
Vlassis Grigoropoulos
American Journal of Ophthalmology, 2014
View PDFchevron_right
The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT study
sara kazerounian
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2017
View PDFchevron_right
Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
Benedicte Lescrauwaet
Patient Related Outcome Measures
View PDFchevron_right
Clinical Course of Vitreomacular Traction Managed Initially by Observation
William Smiddy
Ophthalmic Surgery, Lasers and Imaging Retina, 2015
View PDFchevron_right
Ten Years of Severe Vitreomacular Traction Syndrome without Functional Damage Demonstrated by Optical Coherence Tomography
Michele Reibaldi
Case Reports in Ophthalmological Medicine, 2011
View PDFchevron_right
Impact of Optical Coherence Tomography on Surgical Decision Making for Epiretinal Membranes and Vitreomacular Traction
Syed Mosyab Mehdi Shah
Retina, 2007
View PDFchevron_right
Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy
Pascale Massin
American Journal of Ophthalmology, 2003
View PDFchevron_right
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
Kimberly Drenser
Clinical Ophthalmology, 2021
View PDFchevron_right